Suppr超能文献

美国门诊美沙酮治疗入院延迟的模式。

Patterns in admission delays to outpatient methadone treatment in the United States.

机构信息

Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore MD 21201, USA.

出版信息

J Subst Abuse Treat. 2011 Dec;41(4):431-9. doi: 10.1016/j.jsat.2011.06.005. Epub 2011 Aug 6.

Abstract

Waiting lists for methadone treatment have existed in many U.S. communities, but little is known nationally about what patient and service system factors are related to admission delays that stem from program capacity shortfalls. Using a combination of national data sources, this study examined patterns in capacity-related admission delays to outpatient methadone treatment in 40 U.S. metropolitan areas (N = 28,920). Patient characteristics associated with admission delays included racial/ethnic minority status, lower education, criminal justice referral, prior treatment experience, secondary cocaine or alcohol use, and co-occurring psychiatric problems. Injection drug users experienced fewer delays, as did self-pay patients and referrals from health care and addiction treatment providers. Higher community-level utilization of methadone treatment was associated with delay, whereas delays were less common in communities with higher utilization of alternative modalities. These findings highlight potential disparities in timely admission to outpatient methadone treatment. Implications for improving treatment access and service system monitoring are discussed.

摘要

等候接受美沙酮治疗的名单在美国的许多社区都存在,但全国范围内对于哪些患者和服务系统因素与因项目能力不足而导致的入院延迟有关知之甚少。本研究结合了国家数据源,考察了 40 个美国大都市地区门诊美沙酮治疗相关入院延迟的模式(N=28920)。与入院延迟相关的患者特征包括种族/民族少数群体地位、教育程度较低、刑事司法转介、既往治疗经验、次要可卡因或酒精使用以及同时存在的精神健康问题。注射吸毒者的延迟时间较少,自付患者和来自医疗保健和成瘾治疗提供者的转介也是如此。较高的社区层面的美沙酮治疗利用率与延迟相关,而在替代模式利用率较高的社区,延迟的情况则不太常见。这些发现突出了门诊美沙酮治疗及时入院方面的潜在差异。讨论了改善治疗机会和服务系统监测的意义。

相似文献

1
Patterns in admission delays to outpatient methadone treatment in the United States.
J Subst Abuse Treat. 2011 Dec;41(4):431-9. doi: 10.1016/j.jsat.2011.06.005. Epub 2011 Aug 6.
3
Access to treatment for opioid dependence in rural America: challenges and future directions.
JAMA Psychiatry. 2014 Apr;71(4):359-60. doi: 10.1001/jamapsychiatry.2013.4450.
4
Racial and Ethnic Disparities in Take-Home Methadone Use for Medicare Beneficiaries With Opioid Use Disorder.
JAMA Netw Open. 2024 Aug 1;7(8):e2431620. doi: 10.1001/jamanetworkopen.2024.31620.
6
Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada.
JAMA Netw Open. 2021 Jul 1;4(7):e2118223. doi: 10.1001/jamanetworkopen.2021.18223.
7
A trial of implementation facilitation to increase timely admission to methadone treatment.
J Subst Use Addict Treat. 2024 Jul;162:209375. doi: 10.1016/j.josat.2024.209375. Epub 2024 Apr 19.
8
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.
JAMA Netw Open. 2020 Feb 5;3(2):e1920622. doi: 10.1001/jamanetworkopen.2019.20622.
9
Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts.
Drug Alcohol Depend. 2011 May 1;115(1-2):23-9. doi: 10.1016/j.drugalcdep.2010.10.016. Epub 2010 Dec 3.
10
Medication-assisted recovery from opioid addiction: historical and contemporary perspectives.
J Addict Dis. 2012;31(3):199-206. doi: 10.1080/10550887.2012.694597.

引用本文的文献

2
4
Methadone Treatment Gap in Tennessee and How Medication Units Could Bridge the Gap: A Review.
Pharmacy (Basel). 2023 Aug 22;11(5):131. doi: 10.3390/pharmacy11050131.
5
Typology of laws restricting access to methadone treatment in the United States: A latent class analysis.
Int J Drug Policy. 2023 Sep;119:104141. doi: 10.1016/j.drugpo.2023.104141. Epub 2023 Aug 2.
6
Correlates of Perceived Discrimination Related to Substance Use Disorders Among Patients in Methadone Maintenance Treatment.
J Psychoactive Drugs. 2024 Sep-Oct;56(4):530-540. doi: 10.1080/02791072.2023.2230571. Epub 2023 Jul 3.
8
History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder.
Drug Alcohol Depend Rep. 2023 Jan 10;6:100133. doi: 10.1016/j.dadr.2023.100133. eCollection 2023 Mar.
9
Group-based medical mistrust and care expectations among black patients seeking addiction treatment.
Drug Alcohol Depend Rep. 2022 Jan 18;2:100026. doi: 10.1016/j.dadr.2022.100026. eCollection 2022 Mar.
10
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.
Drug Saf. 2023 Mar;46(3):257-271. doi: 10.1007/s40264-022-01267-z. Epub 2023 Jan 16.

本文引用的文献

1
Interim methadone treatment compared to standard methadone treatment: 4-month findings.
J Subst Abuse Treat. 2011 Jul;41(1):21-9. doi: 10.1016/j.jsat.2011.01.008. Epub 2011 Feb 24.
2
Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.
JAMA. 2010 Oct 13;304(14):1576-83. doi: 10.1001/jama.2010.1427.
3
Impact of interim methadone maintenance on HIV risk behaviors.
J Urban Health. 2010 Jul;87(4):586-91. doi: 10.1007/s11524-010-9451-7.
4
Treatment entry among individuals on a waiting list for methadone maintenance.
Am J Drug Alcohol Abuse. 2009;35(5):290-4. doi: 10.1080/00952990902968577.
5
Interim methadone treatment: impact on arrests.
Drug Alcohol Depend. 2009 Aug 1;103(3):148-54. doi: 10.1016/j.drugalcdep.2009.03.007. Epub 2009 May 14.
6
Evidence for substance abuse services and policy research: a systematic review of national databases.
Eval Rev. 2009 Apr;33(2):103-37. doi: 10.1177/0193841X08328126. Epub 2009 Jan 6.
7
Why don't out-of-treatment individuals enter methadone treatment programmes?
Int J Drug Policy. 2010 Jan;21(1):36-42. doi: 10.1016/j.drugpo.2008.07.004. Epub 2008 Sep 20.
8
When can group level clustering be ignored? Multilevel models versus single-level models with sparse data.
J Epidemiol Community Health. 2008 Aug;62(8):752-8. doi: 10.1136/jech.2007.060798.
9
Drug treatment outcomes for persons on waiting lists.
Am J Drug Alcohol Abuse. 2008;34(5):526-33. doi: 10.1080/00952990802146340.
10
Waiting Time as a Barrier to Treatment Entry: Perceptions of Substance Users.
J Drug Issues. 2006 Sep;36(4):831-852. doi: 10.1177/002204260603600404.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验